跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hospira Gemcitabine Injection (38 mg/mL) 200 mg/5.26 mL (US) - TGA Drug Approval Details
Approvals
/
TGA
/
Hospira Gemcitabine Injection (38 mg/mL) 200 mg/5.26 mL (US)
Approved
STANDARD
Hospira Gemcitabine Injection (38 mg/mL) 200 mg/5.26 mL (US)
Hospira Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f417d9da8ac8bb96
Company
Hospira Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
f417d9da8ac8bb96
Product Name
Hospira Gemcitabine Injection (38 mg/mL) 200 mg/5.26 mL (US)
Artg Id
191593
Artg Name
Hospira Gemcitabine Injection (38 mg/mL) 200 mg/5.26 mL (US)
Sponsor
Hospira Australia Pty Ltd
Company Detail Path
/organization/hospira-australia-pty-ltd
Artg Date
2011-11-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f417d9da8ac8bb96
Type
Standard
Back to TGA Approvals
